Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this research study is to compare the efficacy
(reduction in HbA1c and in blood glucose levels) of insulin detemir once daily injection
compared to insulin detemir twice daily injection administered as basal insulin for the
treatment of type 1 diabetes and to verify the safety of use (number and severity of episodes
of hypoglycemia, body weight and side effects).